Charts of the Day

Harry's Charts of the Day videos are available to members on Monday-Thursday evenings, with one video per week available to non-members. Members please login and see Charts of the Day in the "Videos" menu dropdown.

CREE, EVBG, NTNX, TDOC — Stock Charts to Watch

Charts of the Day video for Tuesday March 6th, 2018


Cree, Inc. (CREE) had a big day on Tuesday with earnings and an acquisition, jumping 3.70, or 10%, to 41.76, on 6.4 million shares traded. It formed an inverse head-and-shoulders, an extended V, and then moved up through resistance. Tuesday’s high at 42.80 is the highest level achieved after breaking out of a 3-year base, and it may very well run into the 50 range, which is the next target.

Everbridge, Inc. (EVBG) broke out on Tuesday, popping 1.86, or 5.58%, to 35.18, on 608,741 shares traded, and took out the Feb high. It is now at the new, all-time, post-IPO high, and is trending towards the 38-40 zone.

NUTANIX, INC. (NTNX) is on the move, gaining another 2.10, or 5%, to 44.13, on 8.3 million shares traded on Tuesday. It has been up three days in a row, and solidly higher, going from 36 to 44 1/2. My target is in the 46-7 zone. It may get there Wednesday morning.

Teladoc, Inc. (TDOC) continues to go, advancing another 1.50, or 3.58%, to 43.45, on 1.2 million shares traded on Tuesday. After the breakout recently, we put a swing on it and it’s extending. The first target was 44-5. It reached 44.68 on Tuesday, so it’s getting close. The second target is 50.

Stocks on the long side included ACM Research, Inc. (ACMR), Baozun Inc. (BZUN), Clearside BioMedical, Inc. (CLSD), Cree, Inc. (CREE), Cronos Group (CRON), Canopy Growth Corporation (TWMJF), Cypress Semiconductor Corporation (CY), Endocyte, Inc. (ECYT), Everbridge, Inc. (EVBG), Fanhua Inc. (FANH), Hortonworks, Inc. (HDP), Intra-Cellular Therapies, Inc. (ITCI), Micron Technology, Inc. (MU), NUTANIX, INC. (NTNX), SMART Global Holdings, Inc. (SGH), Teladoc, Inc. (TDOC), and Xencor, Inc. (XNCR).

©2001-2018 TheTechnicalTrader (, a publication of AdviceTrade, Inc. All rights reserved.